Next article Search Articles Instructions for authors  Access Statistics | Citation Manager  
CASE REPORT  
[LN]

 Article Access Statistics
    Viewed347    
    Printed14    
    Emailed1    
    PDF Downloaded5    
    Comments [Add]    

Recommend this journal


Click on image for details.

 Giant cell tumor of the humeral head treated by denosumab: Implication to shoulder surgeons

Ka Hei Leung1, Albert Ying Lee Lam1, Kenneth Wai Yip Ho1, Tony Wai Hung Shek2
1 Department of Orthopaedics and Traumatology, Division of Anatomical Pathology, Queen Mary Hospital, Hong Kong
2 Department of Pathology, Division of Anatomical Pathology, Queen Mary Hospital, Hong Kong

Correspondence Address:
Ka Hei Leung
Department of Orthopaedics and Traumatology, Queen Mary Hospital, 102 Pokfulam Road
Hong Kong
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-6042.167956

Rights and Permissions

Year : 2015  |  Volume : 9  |  Issue : 4  |  Page : 135-138

 
SEARCH
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles

  Article in PDF (2,368 KB)
Email article
Print Article
Add to My List
Giant cell tumor is a benign bone tumor that is commonly encountered. The optimal treatment of a giant cell tumor which causes extensive bony destruction is controversial. Recent studies on the receptor activator of nuclear factor κB ligand antagonist denosumab may offer a new treatment option for these patients. We presented a patient with giant cell tumor of the humeral head. He was initially treated with denosumab and subsequently with the operation. The shoulder joint was successfully salvaged. But there are potential difficulties that surgeons may face in patients treated with denosumab.






[FULL TEXT] [PDF]*
 

 


Sitemap | What's New | Copyright and Disclaimer
© 2006 - International Journal of Shoulder Surgery
| Published by Wolters Kluwer - Medknow Online since 1st September '06

 

 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 
 
 Reader Comments
 Email Alert *
  *
 * Requires registration (Free)
 
 CASE REPORT
 



Ka Hei Leung1, Albert Ying Lee Lam1, Kenneth Wai Yip Ho1, Tony Wai Hung Shek2
1 Department of Orthopaedics and Traumatology, Division of Anatomical Pathology, Queen Mary Hospital, Hong Kong
2 Department of Pathology, Division of Anatomical Pathology, Queen Mary Hospital, Hong Kong

Correspondence Address:
Ka Hei Leung
Department of Orthopaedics and Traumatology, Queen Mary Hospital, 102 Pokfulam Road
Hong Kong
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0973-6042.167956

Rights and Permissions

Giant cell tumor is a benign bone tumor that is commonly encountered. The optimal treatment of a giant cell tumor which causes extensive bony destruction is controversial. Recent studies on the receptor activator of nuclear factor κB ligand antagonist denosumab may offer a new treatment option for these patients. We presented a patient with giant cell tumor of the humeral head. He was initially treated with denosumab and subsequently with the operation. The shoulder joint was successfully salvaged. But there are potential difficulties that surgeons may face in patients treated with denosumab.






[FULL TEXT] [PDF]*


        
Print this article     Email this article  


Sitemap | What's New | Copyright and Disclaimer
© 2006 - International Journal of Shoulder Surgery
| Published by Wolters Kluwer - Medknow Online since 1st September '06